Article
Investigation of germline GFR alpha-1 mutations in Hirschsprung disease.
Journal of medical genetics - 1 Mar 1999
Myers S M, Salomon R, Goessling A, Pelet A, Eng C, von Deimling A, Lyonnet S, Mulligan L M
Abstract excerpt
Inactivating mutations of the RET proto-oncogene and of one of its soluble ligand molecules, glial cell line derived neurotrophic factor (GDNF), have been found in a subset of patients with Hirschsprung disease (HSCR). However, the majority of HSCR mutations remain unidentified. As normal RET function requires a multicomponent ligand complex for activation, other members of the RET ligand complex are primary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
